Back to top

Image: Bigstock

VIVUS (VVUS) Shows Strength: Stock Adds 5.1% in Session

Read MoreHide Full Article

VIVUS Inc. was a big mover last session, as its shares rose a little more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.04 to $1.17 in the past one-month time frame.

Over the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

VIVUS currently carries a Zacks Rank #2 (Buy).

A similarly ranked stock in the biotechnology space is Arbutus Biopharma Corporation (ABUS - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is VVUS going up? Or down? Predict to see what others think: Up or Down

Zacks’ Best Private Investment Ideas

While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.

Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Arbutus Biopharma Corporation (ABUS) - free report >>

Published in